Insulin Glargine
Long-Acting Insulin- Drug Class
- Long-Acting Insulin
- Mechanism of Action (MOA)
- Basal insulin analog: activates the insulin receptor → ↑ glucose uptake, ↓ hepatic glucose output.
- Clinical Notes
- Peakless ~24-h basal coverage. Hypoglycemia is the key risk; do not mix with other insulins in the same syringe.
- Source
- FDA label (DailyMed)
Sources
Reviewed June 2026- FDA label (DailyMed) — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Same family
Got a pharmacology lecture that covers Insulin Glargine? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology